Vilon
Vilon (Lys-Glu Dipeptide Bioregulator)
Minimal dipeptide bioregulator studied for immune and aging genes
How it works
Vilon is a synthetic dipeptide bioregulator proposed to interact with DNA regions to modulate gene expression - particularly in immune and thymic tissue - reflecting the Khavinson short-peptide bioregulation hypothesis.
What the research explores
In published research, Vilon has been studied in connection with the following. These describe findings reported in the literature — not approved uses, claims, or outcomes to expect.
- Studied as an immune/thymic bioregulator
- Investigated for gene-expression modulation
- Part of the geroprotective bioregulator family
- Researched for age-related immune decline
Vilon is part of Khavinson's short-peptide bioregulator research program, which reports tissue-specific gene-regulatory and geroprotective effects across the peptide-bioregulator family.
Adverse events & gaps
Short dipeptide reported as well tolerated in the bioregulator literature. Profile still being characterized.
Stay Informed on
Peptide Research
Research summaries, newly documented peptides, and clinical trial updates delivered to your inbox.
No spam. Unsubscribe at any time.